US Patent Issued to Xiamen Vivohealths Technology on Sept. 9 for "Substituted imidazole salt compounds, preparation method thereof, pharmaceutical composition thereof and application thereof" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,410,142, issued on Sept. 9, was assigned to Xiamen Vivohealths Technology Co. Ltd. (Fujian, China).

"Substituted imidazole salt compounds, preparation method thereof, pharmaceutical composition thereof and application thereof" was invented by Xianming Deng (Fujian, China), Shengcai Lin (Fujian, China) and Chensong Zhang (Fujian, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed in the invention are a type of compounds having aldolase selective inhibitory activity, a method for the preparation thereof, a pharmaceutical composition comprising the same, and use of these compounds in the manufacture of a medicament for inhibiting triglyceride ...